Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe Wegovy 0.5 mg pre-filled pen delivers its dose through a fixed number of clicks on the dose button — you do not measure the liquid or adjust a dial. Each pen is pre-set at 0.5 mg, so the click count is built in: press and hold until you hear and feel two clicks, which signals that the full 0.5 mg has been injected. That said, the number of audible clicks you count is not the same as the dose in milligrams, and confusing the two is one of the most common questions our prescribers hear. These are prescription-only medicines, and your prescriber and the Patient Information Leaflet are your authoritative guides for anything touching your specific injection technique or schedule.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It happens to almost everyone on their first or second injection. You pressed the button, heard a click, held it, then another click. You pull the pen away and immediately wonder: was that the right dose? Did I count correctly? The short answer is yes, if you heard two distinct clicks while keeping the button fully depressed. The Wegovy pre-filled pen is an auto-injector with a fixed dose mechanism. At the 0.5 mg strength, the pen contains one dose of semaglutide pre-loaded by the manufacturer. There is no way to dial up or dial down. Your only job is to confirm delivery, and the click sequence is how the pen tells you it is done.
The first click signals that the injection has begun. The second click (which you should wait for before removing the pen from your skin) signals the full volume has been expelled. Pulling away after click one, or before click two has fully registered, risks an incomplete injection. Keep the button pressed, keep the pen still, and count to ten after click two before withdrawing. That ten-second hold is specified in the Patient Information Leaflet, and it matters. If you want a broader breakdown of how clicks map across the Wegovy dose range, the Wegovy dose-by-clicks guide covers each pen strength in turn.
A reasonable assumption is that more clicks equals more drug. It does not work that way with the Wegovy pen. The click mechanism is a mechanical release signal, not a volumetric counter. Novo Nordisk designed these pens so that a single, continuous button-press triggers a spring-loaded plunger that expels the pre-measured volume. The clicks you hear are the plunger engaging and completing, not individual incremental doses. At 0.5 mg, the internal volume is small, so the mechanism resolves in two clicks. At the 1 mg strength, the pen still uses the same two-click confirmation, because the pen format is the same; only the pre-filled concentration differs. This is explained in detail in how many clicks are in the Wegovy 0.5 mg pen.
The NHS medicines page for semaglutide directs patients to follow the leaflet that comes with their specific pen, precisely because the administration steps are device-specific and dose-specific. If there is any doubt about your technique after reading that leaflet, contact your prescribing team or pharmacist before your next scheduled injection rather than improvising.
The 0.5 mg pen is the second step in the semaglutide escalation that eventually reaches 2.4 mg maintenance, or 7.2 mg under the newer higher-dose pathway approved by the MHRA in early 2026. Your prescriber moves you to 0.5 mg after four weeks at 0.25 mg, provided the lower dose was tolerated. The purpose of the slow ramp is to give your digestive system time to adjust: the most common side effects of semaglutide are gastrointestinal (nausea, loose stools, indigestion, and occasionally vomiting) and they are most pronounced in the early weeks and after each step up. Most people find they settle within one to two weeks at any given dose.
At 0.5 mg you are not yet at the therapeutic dose; you are still building tolerance. That context matters when you are weighing up whether a missed dose or an uncertain injection affected anything. If you missed a dose entirely and your next scheduled injection is more than five days away, the leaflet advises taking the missed dose as soon as you remember. If it is fewer than five days to your next dose, skip it and continue as normal, your prescriber can confirm this for your specific situation. For a full picture of the dose sequence from 0.25 mg through to maintenance, the Wegovy doses overview sets it out clearly. You can also use the Wegovy dose calculator to understand where you are in the programme. A practical note: many people keep their current pen in the fridge door so it is easy to find on injection day, just remember the pen should come to room temperature for around 30 minutes before use, per the leaflet.
There are situations where the right move is a call, not a calculation. If the pen felt like it jammed, if you saw liquid on your skin after the injection, if the window on the pen did not change colour as expected, or if you are simply not confident the full dose landed, these are questions for your prescriber or pharmacist, not the internet. The same applies if you are experiencing side effects that worry you: severe, persistent abdominal pain that radiates to the back warrants urgent medical attention, as the MHRA has highlighted pancreatitis as a known infrequent but serious risk with GLP-1 medicines. Report any suspected side effects at the MHRA Yellow Card scheme.
Wegovy is a prescription-only medicine, and questions about your dose, your titration timing, or whether to continue after a missed injection all sit with the clinician who prescribed for you. At nume, sorry, at nume, every patient has access to priority aftercare seven days a week, precisely so these questions have a fast route to a real answer. If you are exploring whether Wegovy could be right for you in the first place, the Wegovy overview is the clearest starting point, and you can see where to get Wegovy in the UK if you are weighing up your access options. For anything about costs, the weight-loss treatments page sets out what is included in a single transparent price. When you are ready to speak with a clinician, speak to our prescribers through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.